Lirafugratinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lirafugratinib, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement [Phase 2]